Probe Score Transparency
ImageneBio, Inc. (IMA)
Score window: Apr. 15, 2025 to Apr. 14, 2026
Score Breakdown
Matched Signals
No stored keyword or signal matches were recorded for this score.
Filings In This Window
| Date | Form | Sentiment | Urgency | Summary | Open |
| Sep. 11, 2025 |
CORRESP |
Neutral/Informational |
Moderate |
ImageneBio, Inc. has submitted a request to the SEC for the acceleration of their Registration Statement on Form S-1, seeking to have it become effective by September 15, 2025. Th… |
Read Filing
EDGAR
|
| Sep. 11, 2025 |
UPLOAD |
Neutral/Informational |
Low |
The SEC has communicated to ImageneBio, Inc. that they will not review the company's registration statement filed on September 8, 2025. This indicates that the SEC is not taking a… |
Read Filing
EDGAR
|
| Jun. 10, 2025 |
CORRESP |
Neutral/Informational |
Moderate |
Ikena Oncology, Inc. has submitted a request to the SEC for the acceleration of the effective date of their registration statement on Form S-4. They are seeking to have the regist… |
Read Filing
EDGAR
|
| Jun. 9, 2025 |
CORRESP |
Neutral/Informational |
Moderate |
The correspondence from Goodwin Procter, representing Ikena Oncology, Inc., addresses comments from the SEC regarding Amendment No. 4 to their Registration Statement on Form S-4. … |
Read Filing
EDGAR
|
| Jun. 3, 2025 |
UPLOAD |
Concern from SEC |
High |
The SEC has reviewed the amended registration statement for Ikena Oncology, Inc. and has issued comments requiring further clarification. Specifically, the SEC is seeking informat… |
Read Filing
EDGAR
|
| May. 7, 2025 |
CORRESP |
Neutral/Informational |
Moderate |
The correspondence from Goodwin Procter on behalf of Ikena Oncology, Inc. addresses comments from the SEC regarding their Amendment No. 1 to the Registration Statement on Form S-4… |
Read Filing
EDGAR
|
| May. 2, 2025 |
UPLOAD |
Concern from SEC |
Moderate |
The SEC has reviewed Ikena Oncology, Inc.'s amended registration statement and issued several comments requiring clarification and additional disclosures. Key issues include the n… |
Read Filing
EDGAR
|
| Apr. 21, 2025 |
CORRESP |
Neutral/Informational |
- |
No summary returned. |
Read Filing
EDGAR
|
Notable 8-Ks In This Window
No notable 8-Ks were stored for this company in the score window.